IBALGIN JUNIOR
40MG/ML POR SUS 1X100ML
| SÚKL code | 0229521 |
|---|---|
| Name of the product | IBALGIN JUNIOR |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | IBALGIN JUNIOR |
| Supplement | 40MG/ML POR SUS 1X100ML |
| Strenght | 40MG/ML |
| Pharmaceutical form | Oral suspension |
| Package | 1X100ML |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Bottle |
| Legal status | Selected medicinal products |
| Active substance | IBUPROFEN (IBUPROFENUM) |
| ATC group | M01AE01 |
| ATC group name | IBUPROFEN |
Marketing authorisation information
| Registration Number | 07/ 171/15-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Reference member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 12. 2021 |
| MA Holder | sanofi-aventis, s.r.o., Praha |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | Opella Healthcare Czech s.r.o., Praha |
| Actual MA holder country | ČESKÁ REPUBLIKA |
cz